Knowledge Translation in Practice: Exploring the Potential Use of MCDA in Central America and the Caribbean
We examined the willingness to implement MCDA as a tool to facilitate decision-making in Central America and the Caribbean (CAC). We convene 41 representatives of the healthcare public sector from 10 countries to explore whether they consider MCDA a robust tool to be incorporated in local priority setting processes and which ongoing decision-making process could be benefited from this methodology. We developed a 2-days hands-on training course to explain the technique, advantages and limitations. The group achieved a broad consensus that MCDA can be used in CAC to help priority setting processes because it introduces trans...
Source: Value in Health Regional Issues - October 27, 2018 Category: International Medicine & Public Health Source Type: research
Cultural Adaptation and Linguistic Validation of the Beliefs about Medicines Questionnaire in Malaysia
ConclusionsThe Malay-translated version of BMQ is a reliable and valid tool to assess patient belief about medication, especially medication adherence among the hypertensive patients in Malaysia. (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - October 24, 2018 Category: International Medicine & Public Health Source Type: research
A Review of Studies of Quality of Life for Chinese-Speaking Patients with Ischemic Heart Disease
ConclusionsConsidering the substantial negative impact of IHD from economical, clinical, and humanistic perspectives, psychometric evaluation of core IHD-specific instruments is still needed in patients with IHD and IHD subgroup diseases in Chinese-speaking countries/regions. (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - October 24, 2018 Category: International Medicine & Public Health Source Type: research
Editorial Board
Publication date: May 2018Source: Value in Health Regional Issues, Volume 15Author(s): (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - October 24, 2018 Category: International Medicine & Public Health Source Type: research
Table of Contents
Publication date: May 2018Source: Value in Health Regional Issues, Volume 15Author(s): (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - October 24, 2018 Category: International Medicine & Public Health Source Type: research
Copyright/Subscription
Publication date: May 2018Source: Value in Health Regional Issues, Volume 15Author(s): (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - October 24, 2018 Category: International Medicine & Public Health Source Type: research
New Drug Reimbursement and Pricing Policy in Taiwan
ConclusionsNew drug applications with local pharmacoeconomic studies are more likely to get reimbursement. (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - October 24, 2018 Category: International Medicine & Public Health Source Type: research
Recent Pricing Negotiations on Innovative Medicines Pilot in China: Experiences, Implications, and Suggestions
Publication date: May 2018Source: Value in Health Regional Issues, Volume 15Author(s): Hong Li, Gordon G. Liu, Jing Wu, Jiu-Hong Wu, Chao-Hui Dong, Shan-Lian HuAbstractThe China National Formulary (CNF) for reimbursable drug use, also known as the National Reimbursement Drug List (NRDL), was formally established in 2000, revised in 2004 and 2009, and covers 52% of China’s population under the government urban health insurance programs. A third major and long-awaited update to the formulary was completed in February 2017 based on intensive reviews by a group of experts in medicine, pharmacology, health economics, and heal...
Source: Value in Health Regional Issues - October 24, 2018 Category: International Medicine & Public Health Source Type: research
Health Technology Assessment and Its Use in Drug Policies in China
ConclusionsThe decision makers have realized the importance and value of HTA and have tried to integrate HTA into drug policies and regulations. However, the application of HTA findings to drug policymaking is not yet widespread and there are a number of challenges in using HTA in China. Therefore, it is necessary to establish a national HTA commission and develop pharmacoeconomics guidelines to support the use of HTA in decision making. Moreover, the most important steps are to encourage technology innovation, groom more HTA experts, and build reliable databases in China. (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - October 24, 2018 Category: International Medicine & Public Health Source Type: research
Possibility of Database Research as a Means of Pharmacovigilance in Japan Based on a Comparison with Sertraline Postmarketing Surveillance
ConclusionsOur results support the concept of using database research as a cost-effective pharmacovigilance tool that is free of selection bias . Further investigation using database research is required to confirm our preliminary observations. (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - October 24, 2018 Category: International Medicine & Public Health Source Type: research
How Much Does Management of an Asthma-Related Event Cost in a Malaysian Suburban Hospital?
ConclusionThe microcosting of management of asthma-related events provides more accurate estimates that could be used in local economic studies. However, its possible limited generalizability to other types of health care settings in Malaysia needs to be kept in mind. (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - October 24, 2018 Category: International Medicine & Public Health Source Type: research
Cost-Effectiveness of Warfarin Medication Therapy Adherence Clinic versus Usual Medical Clinic at Kuala Lumpur Hospital
ConclusionsWMTAC is a more cost-effective option than UMC in Kuala Lumpur Hospital. (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - October 24, 2018 Category: International Medicine & Public Health Source Type: research
The Cost and Quality of Life of Malaysian Type 2 Diabetes Mellitus Patients with Chronic Kidney Disease and Anemia
ConclusionsThis study was the first to examine anemia in this group of patients. Costs were significantly higher among anemic patients compared with nonanemic patients; patients with higher CKD stage 5 fared less well than did those in lower stages. This information suggests the need to increase detection, prevention, and early treatment of anemia when managing T2DM patients, particularly those with CKD. (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - October 24, 2018 Category: International Medicine & Public Health Source Type: research
Resource Use and Cost of Treating Human Papillomavirus–Related Lesions in Japanese Women
ConclusionsTo our knowledge, this is the first observational study to estimate the annual medical costs of HPV-related diseases in Japan using real-world data collected in routine clinical practice. It could provide help in estimating the economic burden of HPV-related lesions in Japanese women. (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - October 24, 2018 Category: International Medicine & Public Health Source Type: research
A Comparison of EQ-5D-3L Index Scores Using Malaysian, Singaporean, Thai, and UK Value Sets in Indonesian Cervical Cancer Patients
ConclusionsIn the absence of an Indonesian value set, the Malaysian value set was more preferable to be used compared with the other value sets. Further studies on the development of an Indonesian value set need to be conducted. (Source: Value in Health Regional Issues)
Source: Value in Health Regional Issues - October 24, 2018 Category: International Medicine & Public Health Source Type: research
